Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Rheumatoid Arthritis Practice Performance Project Spots Problems in RA Management

Erin Arnold, MD, William Arnold, MD, Douglas Conaway, MD, Gary Crump, MD, Edmund LaCour, MD, James Mossell, DO, Glen Parris, MD, Kathleen Thomas, DO, David Sikes, MD, Anne Winkler, MD, PhD, MACP, Timothy Harrington, MD, & James Bower, MPA  |  Issue: June 2015  |  

Drs. Erin Arnold, William Arnold, Conaway, Crump, LaCour, Mossell, Parris, Thomas, Sikes and Winkler are clinician rheumatologists participating in the RAPP Project. Dr. Harrington and Mr. Bower are partners in Joiner Associates LLC, the RAPP Project coordinator.

Disclosure Statement

Joiner Associates received consulting fees from Crescendo Bioscience for designing and coordinating the project—without any influence from the company. Crescendo Bioscience has also provided support for participant advisory board meetings for this quality-improvement initiative. The participating clinician authors have reported no other individual disclosures.

ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Harrold LR, Harrington JT, Curtis JR, et al. Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations. Arthritis Rheum. 2012:64(3);630–638.
  2. Smolen JS, Aletaha D, Bijlsma JWJ, et al. Treating rheumatoid arthritis to target: Recommendations of an international task force. Ann Rheum Dis. 2010;69:631–637.
  3. Singh JA, Furst DE, Bharat A, et al. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs ad biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 2012;64:625–639.
  4. Smolen JS, Landwew R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-204573.
  5. Sikes D, Crump G, Thomas K, et al. Population management of rheumatoid arthritis (RA) in rheumatology practices: A quality improvement project. Arthritis Rheumatol: Abstract Supplement. 2014;66(11):S596.
  6. Winkler A, Mossell J, MacLaughlin E, et al. Rheumatoid arthritis (RA) disease activity assessment and population management processes used by clinician rheumatologists. Arthritis Rheumatol: Abstract Supplement. 2014;66(11):S594.
  7. Koster MBM de. Capacity Oriented Analysis and Design of Production Systems. Ed. Beckmann M, Krelle W. Heidelberg: Springer-Verlag, 1989.
  8. Deal CL, Hooker R, Harrington T, et al. The United States rheumatology workforce: Supply and demand, 2005–2025. Arthritis Rheum. 2007 Mar;56(3):722–729.
  9. Harrington JT, Newman ED. Great Health Care: Making It Happen. Ed. Harrington JT, Newman ED. New York, NY: Springer Science + Business Media, 2012.

Related Articles

    9 Steps to Transform Your Rheumatology Practice

    The ACR position statement on access to care proposes the goal that “… all patients have timely access to expert rheuma­tology care … .”1 The reality is that new and established rheumatology patient wait times are often prolonged, causing delays in necessary diagnosis and treatment. The 2005 and 2015 ACR Workforce studies document intractable and…

    workforce

    Addressing the Rheumatology Workforce Shortage

    In 2008, the American College of Rheumatology Workforce Study Advisory Group published a comprehensive rheumatology workforce analysis.1 It concluded: Based on assessment of supply and demand under current scenarios, the demand for rheumatologists is expected to exceed supply in the coming decades. Strategies for the profession to adapt to this changing health care landscape include…

    Letter: Tips to Improve Osteoporosis Screening Rates

    Osteoporosis Screening The aphorism, “Those who do not learn history are doomed to repeat it,” applies to The Rheumatologist August 2017 article that documents the continued low screening rates for those at high risk for osteoporosis-related fragility fractures, in particular people older than 65 and those who have suffered a fracture already. So here’s a…